Universitätsklinikum Frankfurt am Main (KGU)

Hospital


Location: Frankfurt am Main, Germany (DE) DE

ISNI: 0000000405788220

ROR: https://ror.org/03f6n9m15

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Clinical and treatment-related predictors of complete response after total neoadjuvant therapy for rectal cancer in a large multicenter analysis (2026) Wurschi GW, Schneider M, Becker JN, Frerker B, Vorbach SM, Ehret F, Diefenhardt M, et al. Journal article External quality assessment in antimicrobial susceptibility testing (EUCAST disc diffusion methodology) of five anaerobic strains – performance of 35 laboratories in Germany and Austria, 2024 (2026) Buhl M, Jung J, Stingu CS, Copsey-Mawer S, Held J, Haase G, Sieg M, et al. Journal article Advancing CNS tumor diagnostics with expanded DNA methylation-based classification (2026) Sill M, Schrimpf D, Patel A, Sturm D, Jäger N, Sievers P, Schweizer L, et al. Journal article PRDM16 expression is an independent prognostic factor in AML with the double-mutant NPM1/FLT3-ITD genotype (2026) Stasik S, Eckardt JN, Röllig C, Baldus CD, Serve H, Müller-Tidow C, Schäfer-Eckart K, et al. Journal article RT-PCR–Based Detection of Bone Marrow Involvement in Ewing Sarcoma: Diagnostic Validity and Prognostic Relevance (2026) Pham T, Ranft A, Rechl V, Jabar S, Hartmann W, Falkenberg K, Jürgens H, et al. Journal article Role of comorbidities and medication on immunotherapy efficacy in cSCC: A DeCOG multicentre analysis (2026) Geidel G, Bänsch S, Adam L, Fekade N, Rünger A, Zell T, Smit DJ, et al. Journal article Current treatment decisions in cardiac transthyretin amyloidosis: a multicentre analysis (2026) Lavall D, Knoll K, Spethmann S, Hahn K, Barzen G, Winzer EB, Jellinghaus S, et al. Journal article Breaking primary checkpoint inhibitor resistance with intermittent alkylating chemotherapy in patients with metastatic melanoma: results of a multicentre phase II trial. (2026) Haferkamp S, Schilling B, Berking C, Drexler K, Gesierich A, Tomsitz D, Erdmann M, et al. Journal article Randomized Comparison of Cardiotoxicity With 60 Versus 90 mg Daunorubicin in AML Induction Therapy (2026) Dendorfer SM, Schmidt-Brücken K, Kramer M, Steffen B, Schliemann C, Mikesch JH, Alakel N, et al. Journal article High pretreatment peripheral blood T-cell receptor clonality as a predictor of prolonged response in immune thrombocytopenia to the British Journal of Haematology (2026) Schmidt-Barbo P, Schultheiss C, Jauch AJ, Simnica D, Silling G, Hänel M, Chromik J, et al. Journal article